Group One Trading
SWTX

Group One Trading’s SpringWorks Therapeutics SWTX Stock Holding History

Group One Trading’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-255,300
Closed -$12M – 9123
2025
Q2 		$12M Buy
255,300
+123,600
+94% +$5.5M 0.03% 696
2025
Q1 		$5.81M Buy
131,700
+120,300
+1,055% +$5.54M 0.02% 957
2024
Q4 		$412K Buy
11,400
+400
+4% +$14K ﹤0.01% 3332
2024
Q3 		$352K Buy
+11,000
New +$411K ﹤0.01% 3120
2024
Q2 		– Sell
-17,200
Closed -$847K – 7458
2024
Q1 		$847K Buy
17,200
+200
+1% +$9.25K ﹤0.01% 2234
2023
Q4 		$621K Buy
17,000
+9,700
+133% +$253K ﹤0.01% 2888
2023
Q3 		$169K Buy
7,300
+3,600
+97% +$98.4K ﹤0.01% 3951
2023
Q2 		$97K Buy
+3,700
New +$97.2K ﹤0.01% 4658
2023
Q1 		– Sell
-36,600
Closed -$952K – 7940
2022
Q4 		$952K Sell
36,600
-11,300
-24% -$278K ﹤0.01% 2455
2022
Q3 		$1.37M Buy
47,900
+45,500
+1,896% +$1.3M ﹤0.01% 2252
2022
Q2 		$59K Sell
2,400
-17,100
-88% -$625K ﹤0.01% 5429
2022
Q1 		$1.1M Buy
+19,500
New +$1.12M ﹤0.01% 2983

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Group One Trading's SWTX Position: Q1 2025 in Review

Group One Trading sold out of SpringWorks Therapeutics (SWTX) in Q1 2025, closing a stake of 12,898 shares — an estimated $594K sold.

Group One Trading first reported a position in SWTX in Q2 2022 and held it in 7 quarters. The position peaked at $794K in Q1 2024. 306 funds tracked by Wall St. Rank hold SWTX as of Q1 2025.

  • Group One Trading reported no remaining SpringWorks Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 12,898 SpringWorks Therapeutics shares in Q1 2025, an estimated $594K.
  • Group One Trading first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 7 quarters.
  • Group One Trading's SpringWorks Therapeutics position peaked at $794K in Q1 2024.
  • 306 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.